HIVIAIDS INFECTION: 1) Learn about the global epidemiology of HIV infection. (2) Learn about the mechanisms of transmission of infection by HIV, the virus targets, mechanism of action of the virus, natural history of infection. (3) Meet the microbiological techniques for the diagnosis of infection, including rapid diagnostic techniques and techniques for tracking. (4) Know what options there are for the diagnosis of occult infection. (5) Meet the 3 main forms of presentation: acute infection, chronic infection and late diagnosis of infection. Introduction to the main opportunistic diseases currently grouped by CD4 count: infections associated with mild, moderate immunosuppression and severa. 6) Know the most frequent opportunistic infections grouped by syndromes and sorted by severity of immunosuppression. (a) fever and lung infiltrate: bacterial pneumonia, tuberculosis, p. jiroveci pneumonia, Cytomegalovirus, aspergillosis. (b) retinitis: Cytomegalovirus, toxoplasmosis, acute retinal necrosis. Diagnosis and treatment of each one of them. Indications of primary and secondary prophylaxis and commonly used drugs. (7) To know the main causes of space occupying cerebral lesions (toxoplasmosis, tuberculosis, primary Lymphoma of the brain), meningitis (tuberculosis, candida, Cryptococcus), fever (visceral leishmaniasis, MAC, tuberculosis infection) citopenia. (8) Know the therapeutic targets of the virus and the main drugs that act on each one of them. Learn how to create a pattern of anti-retroviral treatment. (9) Understand the objectives of treatment in chronic infection and acute infection and main indications for treatment in infected patients and prevention of infection. Meet the recommended guidelines. Criteria of primary prophylaxis of opportunistic infections and recommended guidelines. (10) Meet the families of antiretroviral toxicity medicines: toxicity associated with analog, not analogue and IPs. Learn about tenofovir / abacavir and drugs toxicity of most recent emergence of first line, such as atazanavir, darunavir and Etravirine raltegravir. (11) to know the main causes of the emergence of resistance. Learn about the concept of primary resistance and acquired resistance. Criteria for application for study of resistance. Learn about the concept of genetic barrier. Classify the family medicine antiretroviral drugs in relation to their genetic barrier and are major mutations associated with resistance to the drug. Current indications from studies of resistance.